The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
March Biosciences and CTMC Form Strategic Alliance to Propel Innovative Cancer Cell Therapies
March Biosciences and CTMC Form Strategic Alliance to Propel Innovative Cancer Cell Therapies Houston, TX – September 11, 2023 – March Biosciences,...
KSQ Therapeutics + CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapies for the Treatment of Solid Tumors
Lexington, Mass., September 6, 2023 — KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its...
CTMC MARKS ONE YEAR OF ACCELERATING LIFE-SAVING CELL THERAPIES TO PATIENTS
Leading Cell Therapy Developer to Attend BIO in Boston, June 5-8 HOUSTON (June 5, 2023) — CTMC, a joint venture between MD Anderson Cancer Center...
Recent News
BioCompare: The Next Generation of CAR T: Building Cancer Killers Inside the Body
by Lauren Tanabe Read the article here:...
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
Author(s)Feliza Mirasol In this episode of Drug Digest, the discussion centers around the optimization of biopharmaceutical manufacturing and supply...
BioProcess International eBook: Autologous Cell Therapies — Shoring Up Supply Chains for Scalability
This eBook collects perspectives from around the cell-therapy industry on ways to ameliorate the scale-related and logistical limitations of...
Tying Advanced Biomanufacturing to a Clinic
By Gail Dutton Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic...
Opinion: To Scale Cell Therapy, Regional Manufacturing Is the Smart Middle Path
By Jane Koo The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between...
Navigating cell therapy’s maze of risks
How a strategic, collaborative approach can accelerate product development and bring cell therapies to patients Jason Bock, Ph.D. Access the...
San Jac interns set standard for biomanufacturing collaboration
Jacquelynn Conger PASADENA, Texas – A transformative partnership between San Jacinto College and CTMC is producing powerful...
What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?
Pharma's Almanac / PAO-09-25-NI-01 Access the article: Pharma's Almanac
HealthBiz Podcast: Delivering on the Promise of CAR T Cell Therapy w/ Dr. Jason Bock
Access the podcast: HealthBiz with David Williams